Heart Test Laboratories (HSCS) Competitors $3.53 +0.02 (+0.57%) As of 09:56 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HSCS vs. PSTV, VVOS, PETV, CODX, PAVM, ALUR, BTCY, SSKN, ICU, and BSGMShould you be buying Heart Test Laboratories stock or one of its competitors? The main competitors of Heart Test Laboratories include Plus Therapeutics (PSTV), Vivos Therapeutics (VVOS), PetVivo (PETV), Co-Diagnostics (CODX), PAVmed (PAVM), Allurion Technologies (ALUR), Biotricity (BTCY), STRATA Skin Sciences (SSKN), SeaStar Medical (ICU), and BioSig Technologies (BSGM). These companies are all part of the "medical equipment" industry. Heart Test Laboratories vs. Plus Therapeutics Vivos Therapeutics PetVivo Co-Diagnostics PAVmed Allurion Technologies Biotricity STRATA Skin Sciences SeaStar Medical BioSig Technologies Plus Therapeutics (NASDAQ:PSTV) and Heart Test Laboratories (NASDAQ:HSCS) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, media sentiment, profitability, dividends, risk, analyst recommendations and community ranking. Does the MarketBeat Community believe in PSTV or HSCS? Plus Therapeutics received 66 more outperform votes than Heart Test Laboratories when rated by MarketBeat users. However, 85.71% of users gave Heart Test Laboratories an outperform vote while only 63.72% of users gave Plus Therapeutics an outperform vote. CompanyUnderperformOutperformPlus TherapeuticsOutperform Votes7263.72% Underperform Votes4136.28% Heart Test LaboratoriesOutperform Votes685.71% Underperform Votes114.29% Is PSTV or HSCS more profitable? Heart Test Laboratories has a net margin of 0.00% compared to Plus Therapeutics' net margin of -225.07%. Plus Therapeutics' return on equity of 0.00% beat Heart Test Laboratories' return on equity.Company Net Margins Return on Equity Return on Assets Plus Therapeutics-225.07% N/A -154.56% Heart Test Laboratories N/A -117.76%-84.09% Do analysts rate PSTV or HSCS? Plus Therapeutics currently has a consensus target price of $11.50, suggesting a potential upside of 1,522.00%. Heart Test Laboratories has a consensus target price of $13.00, suggesting a potential upside of 268.27%. Given Plus Therapeutics' higher probable upside, analysts clearly believe Plus Therapeutics is more favorable than Heart Test Laboratories.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Plus Therapeutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Heart Test Laboratories 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor PSTV or HSCS? In the previous week, Heart Test Laboratories had 2 more articles in the media than Plus Therapeutics. MarketBeat recorded 3 mentions for Heart Test Laboratories and 1 mentions for Plus Therapeutics. Plus Therapeutics' average media sentiment score of 1.89 beat Heart Test Laboratories' score of 0.44 indicating that Plus Therapeutics is being referred to more favorably in the media. Company Overall Sentiment Plus Therapeutics Very Positive Heart Test Laboratories Neutral Which has more risk & volatility, PSTV or HSCS? Plus Therapeutics has a beta of 0.68, suggesting that its stock price is 32% less volatile than the S&P 500. Comparatively, Heart Test Laboratories has a beta of 2.71, suggesting that its stock price is 171% more volatile than the S&P 500. Do insiders and institutionals have more ownership in PSTV or HSCS? 3.3% of Plus Therapeutics shares are owned by institutional investors. Comparatively, 17.2% of Heart Test Laboratories shares are owned by institutional investors. 5.5% of Plus Therapeutics shares are owned by company insiders. Comparatively, 1.8% of Heart Test Laboratories shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has preferable earnings and valuation, PSTV or HSCS? Heart Test Laboratories has lower revenue, but higher earnings than Plus Therapeutics. Heart Test Laboratories is trading at a lower price-to-earnings ratio than Plus Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPlus Therapeutics$4.91M2.45-$13.32M-$2.50-0.28Heart Test Laboratories$14.70K259.59-$6.61M-$7.48-0.47 SummaryPlus Therapeutics beats Heart Test Laboratories on 9 of the 17 factors compared between the two stocks. Get Heart Test Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for HSCS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSCS vs. The Competition Export to ExcelMetricHeart Test LaboratoriesSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.81M$9.15B$5.56B$7.82BDividend YieldN/A1.64%5.11%4.22%P/E Ratio-0.4519.2722.5718.48Price / Sales259.5971.13395.64103.60Price / CashN/A19.6738.1834.62Price / Book0.324.956.774.25Net Income-$6.61M$284.66M$3.22B$248.23M7 Day Performance9.29%0.01%1.46%0.89%1 Month Performance28.36%1.87%3.98%3.53%1 Year Performance-61.88%-17.14%16.14%5.09% Heart Test Laboratories Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSCSHeart Test Laboratories2.2636 of 5 stars$3.53+0.6%$13.00+268.3%-62.0%$3.81M$14,700.00-0.4510Short Interest ↑News CoveragePSTVPlus Therapeutics2.5814 of 5 stars$0.84+30.7%$11.50+1,272.3%-58.7%$14.03M$4.91M-0.3320Positive NewsGap DownVVOSVivos Therapeutics2.7893 of 5 stars$2.35+6.8%$6.10+159.6%+12.3%$13.84M$15.03M-0.41160Short Interest ↓Positive NewsPETVPetVivoN/A$0.52flatN/A-24.1%$12.59M$1.05M-1.1620CODXCo-Diagnostics4.3182 of 5 stars$0.36+0.8%$1.00+179.3%-69.7%$12.02M$3.92M-0.26100Upcoming EarningsAnalyst ForecastNews CoveragePAVMPAVmed4.4067 of 5 stars$0.68+3.5%$19.50+2,776.1%-63.8%$11.59M$3.00M-0.1690Short Interest ↓Gap DownALURAllurion Technologies3.423 of 5 stars$2.30+0.2%$22.83+894.9%-95.2%$11.00M$32.11M-0.19501Positive NewsGap DownBTCYBiotricityN/A$0.44+2.3%N/A-66.4%$10.96M$12.06M-0.4140SSKNSTRATA Skin Sciences3.513 of 5 stars$2.63-2.1%$6.00+128.6%-40.9%$10.95M$33.56M-0.99120Short Interest ↓Positive NewsGap UpICUSeaStar Medical0.6473 of 5 stars$1.24+2.4%N/A-89.3%$10.65M$135,000.00-0.102Short Interest ↓News CoverageGap UpBSGMBioSig Technologies2.272 of 5 stars$0.56+4.0%$2.50+349.6%-38.0%$9.12M$39,000.000.0050Gap Up Related Companies and Tools Related Companies Plus Therapeutics Competitors Vivos Therapeutics Competitors PetVivo Competitors Co-Diagnostics Competitors PAVmed Competitors Allurion Technologies Competitors Biotricity Competitors STRATA Skin Sciences Competitors SeaStar Medical Competitors BioSig Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HSCS) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Heart Test Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Heart Test Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HSCS Stock Free HSCS Stock Alerts